Sign in

CIK 0001321732 · Large accelerated filer

Penumbra Inc

Sign in to watch
Ticker
PEN
Exchange
NYSE
Industry
Surgical & Medical Instruments & Apparatus
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
(510) 995-2486
Business address
ONE PENUMBRA PLACE, ALAMEDA, CA, 94502
  1. SC 13G/A Stake Amended Statement of Ownership
  2. SC 13G/A Stake Amended Statement of Ownership
  3. SC 13G/A Stake Amended Statement of Ownership
  4. 4 Open-market sale CEO and President sold 14,500 shares at an average $253.34 ($3,673,489)
  5. 8-K Event Regulation FD disclosure
  6. 4 Open-market sale Director sold 94 shares at $285.34 ($26,822)
  7. 4 Open-market sale EVP, Gen. Counsel & Secretary sold 3,250 shares at an average $281.57 ($915,093)
  8. 4 Open-market sale Director sold 634 shares at $285.34 ($180,906)
  9. 4 Open-market sale Director sold 80 shares at $283.99 ($22,719)
  10. 4 Option exercise EVP, Gen. Counsel & Secretary acquired 4,800 shares (option exercise)
  11. 4 Shares withheld for taxes Chief Financial Officer gave up 916 shares (to pay taxes)
  12. 4 Open-market sale CEO and President sold 14,500 shares at an average $248.95 ($3,609,715)
  13. 4 Open-market sale EVP, Gen. Counsel & Secretary sold 1,750 shares at an average $246.97 ($432,192)
  14. 4 Open-market sale Director sold 65 shares at $265.36 ($17,248)
  15. 4 Shares withheld for taxes Chief Accounting Officer gave up 130 shares (to pay taxes)
  16. 4 Grant or award Chief Financial Officer acquired 3,750 shares (grant or award)
  17. 4 Grant or award EVP, Gen. Counsel & Secretary acquired 1,500 shares (grant or award)
  18. 4 Open-market sale CEO and President sold 14,500 shares at an average $264.18 ($3,830,628)
  19. 4 Open-market sale EVP, Gen. Counsel & Secretary sold 2,500 shares at an average $279.21 ($698,036)
  20. 10-Q Report Quarterly Report

Page 22 of 48 · 956 filings